Linda Johnson

Read the latest stories and analysis from Linda Johnson.

Johnson & Johnson’s 4Q profit rises 19 percent

Johnson & Johnson’s 4Q profit rises 19 percent

Linda Johnson · January 21, 2014 11:05 pm

Study: Wiser medication use could cut health costs

Study: Wiser medication use could cut health costs

Linda Johnson · June 19, 2013 2:54 pm

Myriad stock volatile after high court gene ruling

Myriad stock volatile after high court gene ruling

Linda Johnson · June 13, 2013 8:42 pm

High court ruling on gene patents lifts Myriad

High court ruling on gene patents lifts Myriad

Linda Johnson · June 13, 2013 7:07 pm

J&J recalls 32M contraceptive packages outside US

J&J recalls 32M contraceptive packages outside US

Linda Johnson · June 4, 2013 8:38 pm

Shares of Merck, Bristol jump on cancer drug news

Shares of Merck, Bristol jump on cancer drug news

Linda Johnson · June 3, 2013 10:07 pm

Valeant to buy Bausch + Lomb for $8.7B

Valeant to buy Bausch + Lomb for $8.7B

Linda Johnson · May 27, 2013 5:08 pm

J&J expects 10-plus new drug applications by 2017

J&J expects 10-plus new drug applications by 2017

Linda Johnson · May 23, 2013 3:58 pm

Pfizer plans offering to pare Zoetis stake

Pfizer plans offering to pare Zoetis stake

Linda Johnson · May 22, 2013 6:03 pm

IMS: US medicine spending shows rare dip in 2012

IMS: US medicine spending shows rare dip in 2012

Linda Johnson · May 9, 2013 4:55 pm

Drugmakers, health groups bring poor girls vaccine

Drugmakers, health groups bring poor girls vaccine

Linda Johnson · May 9, 2013 4:00 am

Shareholders criticize J&J management for lapses

Shareholders criticize J&J management for lapses

Linda Johnson · April 25, 2013 9:59 pm